5 -

5 - Higuchi K, Tanabe S, Shimada K et al. Biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer: a randomised phase III trial (TCOG GI-0801/BIRIP trial). European Journal of Cancer. 2014;50(8):1437-45 [link]